Our Saving grace is Bisantrene still works and has been working quite well. None of the cause of the current downturn, is because we got any bad data.
And Sheba2 results could be our short term saviour, on the basis of which partnerships may eventuate.
I also hope, they hire a CEO asap, with a single minded focus on running with the plan and selling the company within a shorter time-frame(say 2 years).
We are still the world's number one FTO inhibitor.
With so much historical efficacy and data and newly discovered cardioprotection, please set aside your ego for the sake of patients and patient shareholders,and work together , raise some money if you have to, to get it into the clinic as soon as possible.
Ann: Race Board and Management Team Changes, page-224
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
-0.075(4.02%) |
Mkt cap ! $304.8M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.86 | $1.76 | $348.2K | 192.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5612 | $1.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 3567 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.78 |
Change
-0.075 ( 5.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.81 | $1.86 | $1.76 | 27553 | ||
| Last updated 15.55pm 14/06/2024 ? | |||||
| RAC (ASX) Chart |